178 related articles for article (PubMed ID: 29414283)
1. Beneficial effect of plasma exchange in acute attack of neuromyelitis optica spectrum disorders.
Srisupa-Olan T; Siritho S; Kittisares K; Jitprapaikulsan J; Sathukitchai C; Prayoonwiwat N
Mult Scler Relat Disord; 2018 Feb; 20():115-121. PubMed ID: 29414283
[TBL] [Abstract][Full Text] [Related]
2. A pilot study comparing treatments for severe attacks of neuromyelitis optica spectrum disorders: Intravenous methylprednisolone (IVMP) with add-on plasma exchange (PLEX) versus simultaneous ivmp and PLEX.
Songthammawat T; Srisupa-Olan T; Siritho S; Kittisares K; Jitprapaikulsan J; Sathukitchai C; Prayoonwiwat N
Mult Scler Relat Disord; 2020 Feb; 38():101506. PubMed ID: 31731214
[TBL] [Abstract][Full Text] [Related]
3. Treatment of acute relapses in neuromyelitis optica: Steroids alone versus steroids plus plasma exchange.
Abboud H; Petrak A; Mealy M; Sasidharan S; Siddique L; Levy M
Mult Scler; 2016 Feb; 22(2):185-92. PubMed ID: 25921047
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcomes and predictive factors related to good outcomes in plasma exchange in severe attack of NMOSD and long extensive transverse myelitis: Case series and review of the literature.
Aungsumart S; Apiwattanakul M
Mult Scler Relat Disord; 2017 Apr; 13():93-97. PubMed ID: 28427710
[TBL] [Abstract][Full Text] [Related]
5. Retrospective study of the adverse events of the treatment for an acute attack of neuromyelitis optica spectrum disorder.
Veerachit-O-Larn T; Siritho S; Prayoonwiwat N
Ther Apher Dial; 2020 Aug; 24(4):453-460. PubMed ID: 31709734
[TBL] [Abstract][Full Text] [Related]
6. Plasma Exchange for Neuromyelitis Optica Spectrum Disorders in Chinese Patients and Factors Predictive of Short-term Outcome.
Jiao Y; Cui L; Zhang W; Zhang Y; Wang W; Zhang L; Tang W; Jiao J
Clin Ther; 2018 Apr; 40(4):603-612. PubMed ID: 29606515
[TBL] [Abstract][Full Text] [Related]
7. Short delay to initiate plasma exchange is the strongest predictor of outcome in severe attacks of NMO spectrum disorders.
Bonnan M; Valentino R; Debeugny S; Merle H; Fergé JL; Mehdaoui H; Cabre P
J Neurol Neurosurg Psychiatry; 2018 Apr; 89(4):346-351. PubMed ID: 29030418
[TBL] [Abstract][Full Text] [Related]
8. A retrospective cohort study of plasma exchange in central nervous system demyelinating events in children.
Manguinao M; Krysko KM; Maddike S; Rutatangwa A; Francisco C; Hart J; Chong J; Graves JS; Waubant E
Mult Scler Relat Disord; 2019 Oct; 35():50-54. PubMed ID: 31319355
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of apheresis therapy in AQP4 antibody-positive NMOSD attack: A propensity score-matched cohort study.
Xu Y; Wang H; Song T; Yin L; Yao Y; Wei Y; Cong H; Sun J; Zhang X; Tian DC
CNS Neurosci Ther; 2024 May; 30(5):e14780. PubMed ID: 38790106
[TBL] [Abstract][Full Text] [Related]
10. Rescue immunoadsorption treatment for neuromyelitis optica spectrum disorder attacks unresponsive to intravenous methylprednisolone.
Li R; Wang J; Li C; Liu X; Chu M; Chang Y; Wang Y; Wang X; Yu B; Ling L; Yang H; Yang H; Hu X; Qiu W
J Neuroimmunol; 2021 Jul; 356():577604. PubMed ID: 33992860
[TBL] [Abstract][Full Text] [Related]
11. Visual Function Improvement after Plasma Exchange Therapy for Acute Optic Neuritis in Neuromyelitis Optica Spectrum Disorders: Case Series and Review.
Iancu R; Pirvulescu R; Anton N; Iancu G; Istrate S; Romanitan MO; Geamanu A; Popa Cherecheanu M
Diagnostics (Basel); 2024 Apr; 14(9):. PubMed ID: 38732279
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic plasma exchange vs conventional treatment with intravenous high dose steroid for neuromyelitis optica spectrum disorders (NMOSD): a systematic review and meta-analysis.
Siritho S; Nopsopon T; Pongpirul K
J Neurol; 2021 Dec; 268(12):4549-4562. PubMed ID: 33037886
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic Response and Possible Biomarkers in Acute Attacks of Neuromyelitis Optica Spectrum Disorders: A Prospective Observational Study.
Wang J; Cui C; Lu Y; Chang Y; Wang Y; Li R; Shan Y; Sun X; Long Y; Wang H; Wang Z; Lee M; He S; Lu Z; Qiu W; Tan S
Front Immunol; 2021; 12():720907. PubMed ID: 34421925
[TBL] [Abstract][Full Text] [Related]
14. Plasma exchange in severe spinal attacks associated with neuromyelitis optica spectrum disorder.
Bonnan M; Valentino R; Olindo S; Mehdaoui H; Smadja D; Cabre P
Mult Scler; 2009 Apr; 15(4):487-92. PubMed ID: 19324982
[TBL] [Abstract][Full Text] [Related]
15. Clinical experience of plasmapheresis for neuromyelitis optica patients in Mexico.
Gómez-Figueroa E; Alvarado-Bolaños A; García-Estrada C; Zabala-Ángeles I; Sánchez-Rosales N; Bribiesca-Contreras E; García-Alvarez G; Montes-Pérez Y; Ramos-Vega E; Casallas-Vanegas A; Carrillo-Loza K; Corona-Vázquez T; Rivas-Alonso V; Flores-Rivera J
Mult Scler Relat Disord; 2021 Jul; 52():103022. PubMed ID: 34034213
[TBL] [Abstract][Full Text] [Related]
16. Plasma exchange for acute optic neuritis in neuromyelitis optica or neuromyelitis optica spectrum disorder: a systematic review.
Naphattalung Y; Chuenkongkaew WL; Chirapapaisan N; Laowanapiban P; Sawangkul S
Ann Med; 2023 Dec; 55(1):2227422. PubMed ID: 37387119
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of plasma exchange for the treatment of optic neuritis in neuromyelitis optica spectrum disorders: A protocol for systematic review and meta-analysis.
Han M; Chen Y; Nong L; Liu Z; Hao L; Wang Z
Medicine (Baltimore); 2020 Jul; 99(28):e21067. PubMed ID: 32664124
[TBL] [Abstract][Full Text] [Related]
18. ADC restriction is not associated with clinical response to plasma exchange following a cerebral attack of multiple sclerosis.
Jackson-Tarlton C; Londoño D; Lucchinetti CF; Duffy DJ; Weigand SD; Tillema JM; Kalinowska-Lyszczarz A; Tobin WO
Mult Scler Relat Disord; 2023 May; 73():104676. PubMed ID: 37019056
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of intravenous methylprednisolone pulse therapy in patients with multiple sclerosis and neuromyelitis optica.
Yamasaki R; Matsushita T; Fukazawa T; Yokoyama K; Fujihara K; Ogino M; Yokota T; Miyamoto K; Niino M; Nomura K; Tomioka R; Tanaka M; Kawachi I; Ohashi T; Kaida K; Matsui M; Nakatsuji Y; Ochi H; Fukaura H; Kanda T; Nagaishi A; Togo K; Mizusawa H; Murai H; Kira J
Mult Scler; 2016 Sep; 22(10):1337-48. PubMed ID: 26564994
[TBL] [Abstract][Full Text] [Related]
20. Factors associated with the effectiveness of plasma exchange for the treatment of NMO-IgG-positive neuromyelitis optica spectrum disorders.
Lim YM; Pyun SY; Kang BH; Kim J; Kim KK
Mult Scler; 2013 Aug; 19(9):1216-8. PubMed ID: 23263897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
